Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosum
Errataetall: |
CommentOn: J Am Acad Dermatol. 2020 Jan;82(1):254-255. - PMID 31499155 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
---|---|
Enthalten in: |
Journal of the American Academy of Dermatology - 84(2021), 2 vom: 01. Feb., Seite e113 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Katz, Kenneth A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adjuvants, Immunologic |
---|
Anmerkungen: |
Date Completed 23.07.2021 Date Revised 23.07.2021 published: Print-Electronic CommentOn: J Am Acad Dermatol. 2020 Jan;82(1):254-255. - PMID 31499155 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jaad.2020.09.095 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316284858 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316284858 | ||
003 | DE-627 | ||
005 | 20231225160743.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaad.2020.09.095 |2 doi | |
028 | 5 | 2 | |a pubmed24n1054.xml |
035 | |a (DE-627)NLM316284858 | ||
035 | |a (NLM)33058946 | ||
035 | |a (PII)S0190-9622(20)32822-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Katz, Kenneth A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosum |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.07.2021 | ||
500 | |a Date Revised 23.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: J Am Acad Dermatol. 2020 Jan;82(1):254-255. - PMID 31499155 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 7 | |a Adjuvants, Immunologic |2 NLM | |
650 | 7 | |a Aminoquinolines |2 NLM | |
650 | 7 | |a Imiquimod |2 NLM | |
650 | 7 | |a P1QW714R7M |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Academy of Dermatology |d 1984 |g 84(2021), 2 vom: 01. Feb., Seite e113 |w (DE-627)NLM000422703 |x 1097-6787 |7 nnns |
773 | 1 | 8 | |g volume:84 |g year:2021 |g number:2 |g day:01 |g month:02 |g pages:e113 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaad.2020.09.095 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 84 |j 2021 |e 2 |b 01 |c 02 |h e113 |